About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Back to clinical trial search

TERMINATEDNANCT03534466

Evaluation of Long-Term Gait Development in Infants With Neonatal Encephalopathy Using Infant Treadmill

There have been many studies on the use of running training in older children to improve gait development in children with cerebral palsy. The aim of our study was to conduct early treadmill training ...

Lead sponsor: Children's Hospital of Fudan University•1 locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Clareo turns complex medical information into clear understanding you can use.

Bring this clarity to your next appointment.

Keep all your medical notes and next steps in one place.

Sponsors

Lead Sponsor

Children's Hospital of Fudan University

Collaborators

Shanghai High-risk Infants Early Intervention Center

Age

0 - 0 years

Sex

ALL

Healthy Volunteers

No

Inclusion Criteria

•1. Gestational age \< 33W;
•2. Correction of gestational age \< 3 months;
•3. It has been diagnosed as hypoxic-ischemic encephalopathy, periventricular intraventricular hemorrhage, periventricular leukomalacia, bilirubin encephalopathy, persistent hypoglycemia and cerebral infarction.
•4. There was no other therapeutic intervention before entering the study;
•5. Informed consent is signed by the family.

Exclusion Criteria

•1. Brain injury caused by central or peripheral infection (cerebrospinal fluid positive / torch test positive / three major conventional culture positive);
•2. Brain damage caused by convulsion;
•3. Metabolic brain damage caused by genetic defects;
•4. Suffering from known severe congenital malformations;
•5. Definite head trauma during labor or postpartum;
•6. Peripheral neuromuscular disease or abnormal skeletal system.

Related studies

RECRUITINGPhase 1

Dose Optimization of Caffeine for HIE

NCT06448780 · Hypoxic-Ischemic Encephalopathy

RECRUITINGPhase 2

Assess Safety and Efficacy of Sovateltide in Hypoxic-ischemic Encephalopathy

NCT05514340 · Hypoxic-Ischemic Encephalopathy, Neonatal Asphyxia, and more

Randomized Controlled Trial of Early Intensive Leg Exercise to Improve Walking in Children With Diplegia

NCT03672877 · Spastic Diplegia, Periventricular Leukomalacia

Efficacy Evaluation of UCB-MNCs in the Treatment of Refractory Neonatal Diseases

NCT06427642 · Hypoxic-Ischemic Encephalopathy, Bronchopulmonary Dysplasia, and more

Systemic Biomarkers of Brain Injury From Hyperammonemia

NCT04602325 · Urea Cycle Disorder, Organic Acidemia, and more

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: December 29, 2023Terms

Trial snapshot

StatusTERMINATED

PhaseNA

Enrollment20

Start dateDec 2020

Last updatedDec 29, 2023

Condition

Hypoxic-Ischemic Encephalopathy Periventricular Leukomalacia Intraventricular Hemorrhage Neonatal Bilirubin Encephalopathy Kernicterus+2 more

Locations shown

Children Hospital of Fudan University

Shanghai, Shanghai Municipality

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: December 29, 2023Data synced to Clareo: April 28, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions